Results both from flow cytometry analysis for apoptotic cells and from Western blot analysis for apoptosis-associated biomarkers (cleaved caspase 3 and PARP) supported the inhibition by Ambra1 overexpression to the cisplatin-mediated apoptosis induction in PCa DU145 cells. The gene discussed is AMBRA1; the disease is posterior cortical atrophy.